Bracco Imaging has won the Gold Medal from EcoVadis The company is now proudly sporting the EcoVadis gold medal for what it has managed to achieve in four key areas: environment, ethics, labour and human rights, sustainable procurement.

Vueway® (Gadopiclenol) Receives Positive CHMP Opinion The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended approval of the macrocyclic, high-relaxivity Gadopiclenol in adults and pediatric patients older than 2 years of age.

EuSoMII/Bracco AI Contest Pisa, Italy, on the 13th and 14th of October 2023, the European Society of Medical Imaging Informatics hosted its annual gathering. Aptly titled "AI: Connecting the dots," this event brought together minds from different corners of the medical and radiology world to explore the boundless possibilities of Artificial Intelligence.

Bracco group celebrates twenty years of Bracco Spin During the conference “Sustainability, growth, employment: The Torviscosa model,” Bracco announced the plan to expand production capacity at its Torviscosa plant to meet the increasing demand for X-ray contrast agents, and will be making new hires

Diana Bracco: “we put people at the heart of sustainable development” During the conference "Sustainability, growth, employment: the Torviscosa model,” the Bracco Group presented its new Sustainability Report. The Report enumerates all the actions that Bracco, global leader in diagnostic imaging, has taken in favour of people, the planet and innovation.

Bracco announces long term strategic partnership with ulrich medical The partnership will bring a Bracco branded state of the art MR injector to the United States under an exclusive private label arrangement.

The EC granted Marketing Authorisation for Vueway® (gadopiclenol) in the European Union Vueway®, a new macrocyclic gadolinium-based contrast agent for CE-MRI, received Marketing Authorisation in the European Union By European Commission.

ECR2024 Bracco@ECR2024, where education meets innovation to shape the future of medical imaging.

Samsung Medison and Bracco Imaging announce a new agreement Samsung Medison and Bracco Imaging endorsed a Memorandum of Understanding agreement to pioneer a new area for diagnostic ultrasound device and contrast agent at European Congress of Radiology 2024 held in Vienna, Austria on February 28th to March 3rd.

Which value does Bracco give to education? At ECR2024, Francesca Pelliconi, Strategy & Operations Director, Global Marketing at Bracco Imaging, engaged in a conversation with Guido Gebhardt of Diagnostic Imaging Europe (DIE), the leading pan-European resource for medical imaging news, analysis, and trends.